BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 23997182)

  • 1. An immunodominant HLA-A*1101-restricted CD8+ T-cell response targeting hepatitis B surface antigen in chronic hepatitis B patients.
    Chen X; Wang W; Wang S; Meng G; Zhang M; Ni B; Wu Y; Wang L
    J Gen Virol; 2013 Dec; 94(Pt 12):2717-2723. PubMed ID: 23997182
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunogenicity of twenty peptides representing epitopes of the hepatitis B core and surface antigens by IFN-γ response in chronic and resolved HBV.
    Brinck-Jensen NS; Vorup-Jensen T; Leutscher PD; Erikstrup C; Petersen E
    BMC Immunol; 2015 Nov; 16():65. PubMed ID: 26526193
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of HLA-A*0201-restricted CD8+ T-cell epitope C₆₄₋₇₂ from hepatitis B virus core protein.
    Liu Q; Zheng Y; Yu Y; Tan Q; Huang X
    Int Immunopharmacol; 2012 Jun; 13(2):141-7. PubMed ID: 22480777
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Purification and characterization of a naturally processed hepatitis B virus peptide recognized by CD8+ cytotoxic T lymphocytes.
    Tsai SL; Chen MH; Yeh CT; Chu CM; Lin AN; Chiou FH; Chang TH; Liaw YF
    J Clin Invest; 1996 Jan; 97(2):577-84. PubMed ID: 8567982
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Detection of antigen-epitope-specific cytotoxic T lymphocytes in patients with hepatitis B virus infection by enzyme linked immunospot assay].
    Zhang HP; Yan HP; Zhang YH; Feng X; Zhao Y; Liao HY; Liu YM; Chen Y; Tan YF; Liu Y
    Zhonghua Yu Fang Yi Xue Za Zhi; 2009 Aug; 43(8):690-4. PubMed ID: 20021848
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD8
    Zhang Y; Wu Y; Deng M; Xu D; Li X; Xu Z; Hu J; Zhang H; Liu K; Zhao Y; Gao F; Bi S; Gao GF; Zhao J; Liu WJ; Meng S
    J Virol; 2018 Sep; 92(17):. PubMed ID: 29950410
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasmacytoid dendritic cells induce efficient stimulation of antiviral immunity in the context of chronic hepatitis B virus infection.
    Martinet J; Leroy V; Dufeu-Duchesne T; Larrat S; Richard MJ; Zoulim F; Plumas J; Aspord C
    Hepatology; 2012 Nov; 56(5):1706-18. PubMed ID: 22707082
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunoprevalence and immunodominance of HLA-Cw*0801-restricted T cell response targeting the hepatitis B virus envelope transmembrane region.
    Tan AT; Sodsai P; Chia A; Moreau E; Chng MH; Tham CY; Ho ZZ; Banu N; Hirankarn N; Bertoletti A
    J Virol; 2014 Jan; 88(2):1332-41. PubMed ID: 24227846
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel T-cell epitope in the transmembrane region of the hepatitis B virus envelope protein responds upon dendritic cell expansion.
    Chen L; Zhang Y; Zhang S; Chen Y; Shu X; Lai J; Cao H; Lian Y; Stamataki Z; Huang Y
    Arch Virol; 2019 Feb; 164(2):483-495. PubMed ID: 30415392
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic polypeptides based on HBcAg(18-27) CTL epitope can induce antigen-specific CD(8)(+) CTL-mediated cytotoxicity in HLA-A2 transgenic mice.
    Shi TD; Wu YZ; Jia ZC; Zhou W; Zou LY
    World J Gastroenterol; 2004 Apr; 10(8):1222-6. PubMed ID: 15069731
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HLA-A31- and HLA-Aw68-restricted cytotoxic T cell responses to a single hepatitis B virus nucleocapsid epitope during acute viral hepatitis.
    Missale G; Redeker A; Person J; Fowler P; Guilhot S; Schlicht HJ; Ferrari C; Chisari FV
    J Exp Med; 1993 Mar; 177(3):751-62. PubMed ID: 7679709
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decades after recovery from hepatitis B and HBsAg clearance the CD8+ T cell response against HBV core is nearly undetectable.
    Kefalakes H; Jochum C; Hilgard G; Kahraman A; Bohrer AM; El Hindy N; Heinemann FM; Verheyen J; Gerken G; Roggendorf M; Timm J
    J Hepatol; 2015 Jul; 63(1):13-9. PubMed ID: 25646888
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selection of hepatitis B virus variants with aminoacid substitutions inside the core antigen during interferon-alpha therapy.
    Radecke K; Protzer U; Trippler M; Meyer Zum Büschenfelde KH; Gerken G
    J Med Virol; 2000 Dec; 62(4):479-86. PubMed ID: 11074477
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recognition of Core- and Polymerase-derived immunogenic peptides included in novel therapeutic vaccine by T cells from Chinese chronic hepatitis B patients.
    Huang D; Sansas B; Jiang JH; Gong QM; Jin GD; Calais V; Yu DM; Zhu MY; Wei D; Zhang DH; Inchauspé G; Zhang XX; Zhu R
    J Viral Hepat; 2017 Nov; 24 Suppl 1():66-74. PubMed ID: 29082648
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Spatiotemporal Differences in Presentation of CD8 T Cell Epitopes during Hepatitis B Virus Infection.
    Khakpoor A; Ni Y; Chen A; Ho ZZ; Oei V; Yang N; Giri R; Chow JX; Tan AT; Kennedy PT; Maini M; Urban S; Bertoletti A
    J Virol; 2019 Feb; 93(4):. PubMed ID: 30518652
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Direct analysis of HBV-specific CD8+ lymphocyte by tetrameric HLA-A2/core 18-27 complex in chronic Hepatitis B].
    Lee CK; Suh JH; Cho YS; Han KH; Chung JB; Chon CY; Moon YM
    Taehan Kan Hakhoe Chi; 2002 Jun; 8(2):139-48. PubMed ID: 12499799
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Type I Interferon Signaling Prevents Hepatitis B Virus-Specific T Cell Responses by Reducing Antigen Expression.
    Kawashima K; Isogawa M; Hamada-Tsutsumi S; Baudi I; Saito S; Nakajima A; Tanaka Y
    J Virol; 2018 Dec; 92(23):. PubMed ID: 30209178
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Frequencies and characterization of HBV-specific cytotoxic T lymphocytes in self-limited and chronic hepatitis B viral infection in China.
    Yang X; Hao Y; Liu Z; Chen L; Ding H; Zhao X; Lu M; Yang D
    J Huazhong Univ Sci Technolog Med Sci; 2009 Oct; 29(5):567-74. PubMed ID: 19821088
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elimination of immunodominant epitopes from multispecific DNA-based vaccines allows induction of CD8 T cells that have a striking antiviral potential.
    Riedl P; Wieland A; Lamberth K; Buus S; Lemonnier F; Reifenberg K; Reimann J; Schirmbeck R
    J Immunol; 2009 Jul; 183(1):370-80. PubMed ID: 19542448
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytotoxic T lymphocyte responses and CTL epitope escape mutation in HBsAg, anti-HBe positive individuals.
    Khakoo SI; Ling R; Scott I; Dodi AI; Harrison TJ; Dusheiko GM; Madrigal JA
    Gut; 2000 Jul; 47(1):137-43. PubMed ID: 10861276
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.